Resistin overexpression is induced by a beta3 adrenergic agonist in diet-related overweightness by Martinez, J.A. (José Alfredo) et al.
J. Physiol. Biochem., 57 (3), 287-288, 2001
Resistin overexpression is induced by a P3 adrenergic
agonist in diet-related overweightness
Resistin, a recently discovered 12.5
KDa cysteine rich adipose tissue specific
secretory factor, has been suggested as a
new hormone involved in insulin resis-
tance, which may link obesity with type-2
diabetes (10). This protein released by
brown and white adipose tissues appears
to participate in the body's ability to
respond to insulin together with other
molecules secreted by the adipocyte such
as free fatty acids, leptin or tumor necro-
sis factor (1, 4). Circulating resistin levels
are increased in diet-induced and genetic
models of obesity, while the administra-
tion of recombinant resistin to normal
mice impairs glucose tolerance and insulin
functions (10). However, some of these
results have been challenged by a later
report, in which it has been shown that
resistin expression in fat cell is suppressed
in situations of obesity (12). The aim of
the current investigation was to evaluate
adipocyte mRNA levels in high-fat fed
animals (cafeteria diet) and the influence
of the treatment with the J33-adrenergic
agonist tertratolol in overweight animals.
In this context, twenty six female rats
weighing between 150-175 g were
assigned to three groups, which received
the experimental diets and intraperitoneal
placebo or tertratolol administration for
30 days: control diet and placebo (n=10),
cafeteria fed and placebo (n=8) and cafete-
ria fed animals treated with the 133 adren-
ergic agonist (n=8). All procedures were
performed according to national and insti-
tutional guidelines for animal care and U3e
at the University of Navarra. The extrac-
tion of total RNA and serniquantitation
by reverse-transcription polymerase chain
reaction (RT-PCR) were carried out as
previously described (3, 7). The primer to
amplify resistin DNA was: Upper
5' CAGAAGGCACAACCGTCA-3 and
Lower 5' TCAGGAACCAACC-
CGCAG-3 (Annealing, 58°C; elongation,
72 DC and cycles, 32 DC ), which was
designed using the nucleotide sequence
reported by KIM et al (6) and the oligo
4.05 Primer Analysis software (Phymouth
MN). To ensure the linearity of PCR
reactions and to validate the eDNA quan-
tification, adequate controls and standard
curves were performed as reported else-
where (3). Levels of messenger RNA were
measured as the ratio of signal intensity
relative to ~-actin by densitometric analy-
sis with adequate imaging software (Bio.
Red Hercules, CA). Data were analysed
using an ANOVA design followed by an
appropriate a posteriori test (Dunnett T
Test: one tail).
High fat feeding significantly (p<O.OI)
increased body weight in those animals
receiving the cafeteria diet and placebo
(308.0 ± 7.3 g) as compared to controls
(266.3 ± 4.4 g), while the tertratolol treat-
ment to high-fat fed rats significantly
(p<0.05) prevented the excessive weight
gain induced by the cafeteria regime
(284.1 ± 7.6 g). Also, fat depots (perirenal,
periovaric and abdominal regions) were
influenced (p<O.OI) by the dietary and
pharmacological conditions (control diet:
7.0 ± O.7g; cafeteria diet: 20.8 ± 2.2 g, and
cafeteria diet with ~3 adrenergic treat-
ment: 12.6 ± 2.0 g).
Interestingly (Fig. 1), the resistin
mRNA levels (arbitrary units) in adipose
tissue, which remained unaffected in con-
trol and overweight animals receiving the
cafeteria diet, were doubled by the ~3
agonist administration.
Resistin and RELMs (resistin-like mol-
ecules) constitute a new family of tissue-
specific signaling molecules (11) with a
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Fig. 1. Resistin mRNA expression levels (arbitrary
units) in white adipose tissue as affected by the diet
and 133 adrenergic administration.
*p < 0.05 vs. control.
restricted distribution in rodent and
human tissues. Resistin mRNA levels
were markedly increased during 3T3-L1
and primary cell differentiation into
adipocytes, whose expression appears to
be under a tight nutritional and hormonal
regulation; however, intriguing outcomes
have been observed in obese animals,
where some authors (10) have found an
increase in circulatory levels of resistin,
while others reported a severe suppression
of the adipose tissue resistin expression
(12). Our data revealed no changes in
resistin mRNA levels in cafeteria fed ani-
mals, which may be explained by the fact
that gene expression trends and some gene
products secretion may follow different
patterns (2), but also by the dietary and
experimental conditions (timing, diet
composition, strain resistance to obesity,
etc.). In an earlier study, we found a dual
time-dependent effect of a high energy
yielding diet on the expression of some
adipogenesis related genes such a PPAR'Y
and aP2 (7).
Compounds with affinity for ~3
adrenoceptors have shown antidiabetic
and antiobesity properties (8). In this con-
text, it is reported apparently for the first
time, that ~3 adrenoceptor stimulation in
diet-induced obese animals produces an Martinez, J.A., Margareto, J., Marti, A., Mila-
gro, F. I., Larrarte, E. and Moreno Aliaga, M. J.
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increase in resistin gene expression. This
finding is in agreement with data concern-
ing other antidiabetic compounds such as
PP ARY agonists, which increase resistin
expression in WAT. Also, a recent report
using BRL-35135 reveals that RELMa
mRNA was increased in db/db mice (9).
Further studies are needed to determine
the biological functions, the mode of
action and regulation of resistin (1, 4, 5) as
well its possible role as effector of insulin
resistance in obesity; however, this factor
appears to be involved in adipose metabo-
lism control with potential implications in
the energy balance.
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